chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Chills, Rash erythematous, Rhinorrhoea, Vaccination site erythema, Vaccination site pain
Clinical narrative: redness at the site of injection; Sunburn-like rash at the site of the injection on left arm; Warmth at the site of the injection on left arm; Itching at the site of the injection on left arm; Pain at the site of the injection on left arm; chills; Runny nose; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose), RASH ERYTHEMATOUS (Sunburn-like rash at the site of the injection on left arm), VACCINATION SITE WARMTH (Warmth at the site of the injection on left arm), VACCINATION SITE PRURITUS (Itching at the site of the injection on left arm) and VACCINATION SITE PAIN (Pain at the site of the injection on left arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CLOPIDOGREL, PANTOPRAZOLE, ZOLPIDEM and CICLOSPORIN (RESTASIS) for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced RHINORRHOEA (Runny nose) and CHILLS (chills). On 16-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Sunburn-like rash at the site of the injection on left arm), VACCINATION SITE WARMTH (Warmth at the site of the injection on left arm), VACCINATION SITE PRURITUS (Itching at the site of the injection on left arm) and VACCINATION SITE PAIN (Pain at the site of the injection on left arm). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness at the site of injection). At the time of the report, RHINORRHOEA (Runny nose) and CHILLS (chills) had resolved and RASH ERYTHEMATOUS (Sunburn-like rash at the site of the injection on left arm), VACCINATION SITE WARMTH (Warmth at the site of the injection on left arm), VACCINATION SITE PRURITUS (Itching at the site of the injection on left arm), VACCINATION SITE PAIN (Pain at the site of the injection on left arm) and VACCINATION SITE ERYTHEMA (redness at the site of injection) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included diphenhydramine.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site warmth
Clinical narrative: redness at the site of injection; Sunburn-like rash at the site of the injection on left arm; Warmth at the site of the injection on left arm; Itching at the site of the injection on left arm; Pain at the site of the injection on left arm; chills; Runny nose; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose), RASH ERYTHEMATOUS (Sunburn-like rash at the site of the injection on left arm), VACCINATION SITE WARMTH (Warmth at the site of the injection on left arm), VACCINATION SITE PRURITUS (Itching at the site of the injection on left arm) and VACCINATION SITE PAIN (Pain at the site of the injection on left arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CLOPIDOGREL, PANTOPRAZOLE, ZOLPIDEM and CICLOSPORIN (RESTASIS) for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced RHINORRHOEA (Runny nose) and CHILLS (chills). On 16-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Sunburn-like rash at the site of the injection on left arm), VACCINATION SITE WARMTH (Warmth at the site of the injection on left arm), VACCINATION SITE PRURITUS (Itching at the site of the injection on left arm) and VACCINATION SITE PAIN (Pain at the site of the injection on left arm). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness at the site of injection). At the time of the report, RHINORRHOEA (Runny nose) and CHILLS (chills) had resolved and RASH ERYTHEMATOUS (Sunburn-like rash at the site of the injection on left arm), VACCINATION SITE WARMTH (Warmth at the site of the injection on left arm), VACCINATION SITE PRURITUS (Itching at the site of the injection on left arm), VACCINATION SITE PAIN (Pain at the site of the injection on left arm) and VACCINATION SITE ERYTHEMA (redness at the site of injection) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included diphenhydramine.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache, Pain, Vaccination site pain
Clinical narrative: whole body pain; weakness; headache; left arm aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (whole body pain), ASTHENIA (weakness), HEADACHE (headache) and VACCINATION SITE PAIN (left arm aches) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21E) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (whole body pain), ASTHENIA (weakness), HEADACHE (headache) and VACCINATION SITE PAIN (left arm aches). At the time of the report, PAIN (whole body pain), ASTHENIA (weakness), HEADACHE (headache) and VACCINATION SITE PAIN (left arm aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Chills, Depressed mood, Diarrhoea, Headache
Clinical narrative: felt weak legs; felt herself miserable; still "throw up"; extremely bad shaking; real bad severe diarrhea; headache; extreme nausea; chills; little anxiety; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MUSCULAR WEAKNESS (felt weak legs), DEPRESSED MOOD (felt herself miserable), ANXIETY (little anxiety), TREMOR (extremely bad shaking) and DIARRHOEA (real bad severe diarrhea) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hodgkin's lymphoma. Concomitant products included AMLODIPINE, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE, ZOLPIDEM, ACETYLSALICYLIC ACID (ASPIRIN 81) and OMEPRAZOLE for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced ANXIETY (little anxiety). On 25-Mar-2021, the patient experienced TREMOR (extremely bad shaking), DIARRHOEA (real bad severe diarrhea), HEADACHE (headache), NAUSEA (extreme nausea) and CHILLS (chills). On 26-Mar-2021, the patient experienced DEPRESSED MOOD (felt herself miserable) and VOMITING (still "throw up"). On 27-Mar-2021, the patient experienced MUSCULAR WEAKNESS (felt weak legs). On 25-Mar-2021, ANXIETY (little anxiety), TREMOR (extremely bad shaking), DIARRHOEA (real bad severe diarrhea), HEADACHE (headache) and CHILLS (chills) had resolved. On 26-Mar-2021, NAUSEA (extreme nausea) had resolved. At the time of the report, MUSCULAR WEAKNESS (felt weak legs), DEPRESSED MOOD (felt herself miserable) and VOMITING (still "throw up") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included IV Hydration and IV infusion with Zofran.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow up received on 12-May-2021 and patient medical history was added.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Nausea, Tremor, Vomiting
Clinical narrative: felt weak legs; felt herself miserable; still "throw up"; extremely bad shaking; real bad severe diarrhea; headache; extreme nausea; chills; little anxiety; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MUSCULAR WEAKNESS (felt weak legs), DEPRESSED MOOD (felt herself miserable), ANXIETY (little anxiety), TREMOR (extremely bad shaking) and DIARRHOEA (real bad severe diarrhea) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hodgkin's lymphoma. Concomitant products included AMLODIPINE, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE, ZOLPIDEM, ACETYLSALICYLIC ACID (ASPIRIN 81) and OMEPRAZOLE for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced ANXIETY (little anxiety). On 25-Mar-2021, the patient experienced TREMOR (extremely bad shaking), DIARRHOEA (real bad severe diarrhea), HEADACHE (headache), NAUSEA (extreme nausea) and CHILLS (chills). On 26-Mar-2021, the patient experienced DEPRESSED MOOD (felt herself miserable) and VOMITING (still "throw up"). On 27-Mar-2021, the patient experienced MUSCULAR WEAKNESS (felt weak legs). On 25-Mar-2021, ANXIETY (little anxiety), TREMOR (extremely bad shaking), DIARRHOEA (real bad severe diarrhea), HEADACHE (headache) and CHILLS (chills) had resolved. On 26-Mar-2021, NAUSEA (extreme nausea) had resolved. At the time of the report, MUSCULAR WEAKNESS (felt weak legs), DEPRESSED MOOD (felt herself miserable) and VOMITING (still "throw up") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included IV Hydration and IV infusion with Zofran.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow up received on 12-May-2021 and patient medical history was added.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: Red welps from knees up to neck; Rash all over body; Body itch/ mild itching; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Body itch/ mild itching), ERYTHEMA (Red welps from knees up to neck) and RASH (Rash all over body) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic. Concomitant products included METFORMIN, LISINOPRIL, SIMVASTATIN, CYANOCOBALAMIN (VIT B12), INSULIN GLARGINE, LIXISENATIDE (SOLIQUA), TOCOPHEROL (VIT E [TOCOPHEROL]) and INSULIN for an unknown indication.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRURITUS (Body itch/ mild itching). On 13-Mar-2021 at 10:00 AM, the patient experienced RASH (Rash all over body). On 15-Mar-2021, the patient experienced ERYTHEMA (Red welps from knees up to neck). The patient was treated with PREDNISONE ongoing from 15-Mar-2021 at a dose of 2 dosage form once a day; PREDNISONE from 07-Apr-2021 to 02-May-2021 at a dose of 3 dosage form once a day and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (Body itch/ mild itching) and RASH (Rash all over body) had not resolved and ERYTHEMA (Red welps from knees up to neck) outcome was unknown.            Treatment for the events included diphenhydramine (Benadryl), Benadryl IV, Prednisone. Action taken with mRNA-1273 in response to the events was not applicable. On 14-Mar-2021, the patient went to urgent care and was given Benadryl  IV and tablet. The itching still did not stop. On 15-Mar-2021, she again went to urgent care. She was completely covered in red welps from knees up to neck. Prednisone 2 tablets once daily was started and was referred to an Allergy Specialist and was ordered a blood test.On 29-Apr-2021 she was sent to see a Urologist. She still continued to have mild itching and body sores.   This case was linked to MOD-2021-135137, MOD-2021-135137 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Follow up received on 14-May-2021 and Added HCP details, patient demographics, relevant medical history (Allergy: Tetracycline, Current condition: Diabetic). New concomitant medications (Insulin, Prednisone) added. New events Body itch and Red whelps from knees up to neck added. The outcome of the event Full body rash changed (from Resolved to Not resolved).
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: extreme vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (extreme vertigo) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included DORZOLAMIDE HYDROCHLORIDE, TIMOLOL MALEATE (DORZOLAMIDE/TIMOLOL ACTAVIS) and BIMATOPROST (LUMIGAN) for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced VERTIGO (extreme vertigo). At the time of the report, VERTIGO (extreme vertigo) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea, Pyrexia
Clinical narrative: headache; fever; nausea; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), PYREXIA (fever), NAUSEA (nausea), CHILLS (chills) and FATIGUE (fatigue) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced HEADACHE (headache), PYREXIA (fever), NAUSEA (nausea), CHILLS (chills) and FATIGUE (fatigue). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, HEADACHE (headache), PYREXIA (fever), NAUSEA (nausea), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants were reported.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pain in extremity, Peripheral swelling
Clinical narrative: Achy after 1st dose; Arm really swollen after 1st dose; Arm really sore after 1st dose; a little tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy after 1st dose), PERIPHERAL SWELLING (Arm really swollen after 1st dose), PAIN IN EXTREMITY (Arm really sore after 1st dose) and FATIGUE (a little tired) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022m20a and 046a21a) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced PAIN (Achy after 1st dose), PERIPHERAL SWELLING (Arm really swollen after 1st dose), PAIN IN EXTREMITY (Arm really sore after 1st dose) and FATIGUE (a little tired). At the time of the report, PAIN (Achy after 1st dose), PERIPHERAL SWELLING (Arm really swollen after 1st dose), PAIN IN EXTREMITY (Arm really sore after 1st dose) and FATIGUE (a little tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Fever; Chills; Muscle Ache; Headache; Tiredness; Injection Arm Hurting; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle Ache), HEADACHE (Headache) and FATIGUE (Tiredness) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle Ache), HEADACHE (Headache), FATIGUE (Tiredness) and VACCINATION SITE PAIN (Injection Arm Hurting). At the time of the report, PYREXIA (Fever) and CHILLS (Chills) had not resolved and MYALGIA (Muscle Ache), HEADACHE (Headache), FATIGUE (Tiredness) and VACCINATION SITE PAIN (Injection Arm Hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Fever; Chills; Muscle Ache; Headache; Tiredness; Injection Arm Hurting; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle Ache), HEADACHE (Headache) and FATIGUE (Tiredness) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle Ache), HEADACHE (Headache), FATIGUE (Tiredness) and VACCINATION SITE PAIN (Injection Arm Hurting). At the time of the report, PYREXIA (Fever) and CHILLS (Chills) had not resolved and MYALGIA (Muscle Ache), HEADACHE (Headache), FATIGUE (Tiredness) and VACCINATION SITE PAIN (Injection Arm Hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, COVID-19, Pyrexia, SARS-CoV-2 test
Clinical narrative: COVID -19 Positive after the first dose; Fever 102.2degree F; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID -19 Positive after the first dose) and PYREXIA (Fever 102.2degree F) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     The patient's past medical history included Heart disorder, Lung cancer (Stage 1 Lung Cancer) and Surgery (Lung surgery that removed 1/3 of lung). Concomitant products included LISINOPRIL, PRAVASTATIN, CARVEDILOL (COREG) and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced PYREXIA (Fever 102.2degree F). On 26-Mar-2021, the patient experienced COVID-19 (COVID -19 Positive after the first dose). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID -19 Positive after the first dose) outcome was unknown and PYREXIA (Fever 102.2degree F) was resolving. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Mar-2021, Body temperature increased: elevated (High) 102.2. On 24-Mar-2021, SARS-CoV-2 test: negative (Negative) Negative. On 26-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient reports taking a WATER PILL (NOS).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Influenza like illness, Nausea
Clinical narrative: feels like she has the flu; joint pain; headache; fever; chills; feels nauseous; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (feels like she has the flu), ARTHRALGIA (joint pain), HEADACHE (headache), PYREXIA (fever) and CHILLS (chills) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included OMEPRAZOLE, ALPRAZOLAM (XANAX), GABAPENTIN, TRAMADOL, LAMOTRIGINE, ATORVASTATIN and LORATADINE (CLARITIN [LORATADINE]) for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (feels like she has the flu), ARTHRALGIA (joint pain), HEADACHE (headache), PYREXIA (fever), CHILLS (chills) and NAUSEA (feels nauseous). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (feels like she has the flu), ARTHRALGIA (joint pain), HEADACHE (headache), PYREXIA (fever), CHILLS (chills) and NAUSEA (feels nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       .
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: feels like she has the flu; joint pain; headache; fever; chills; feels nauseous; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (feels like she has the flu), ARTHRALGIA (joint pain), HEADACHE (headache), PYREXIA (fever) and CHILLS (chills) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included OMEPRAZOLE, ALPRAZOLAM (XANAX), GABAPENTIN, TRAMADOL, LAMOTRIGINE, ATORVASTATIN and LORATADINE (CLARITIN [LORATADINE]) for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (feels like she has the flu), ARTHRALGIA (joint pain), HEADACHE (headache), PYREXIA (fever), CHILLS (chills) and NAUSEA (feels nauseous). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (feels like she has the flu), ARTHRALGIA (joint pain), HEADACHE (headache), PYREXIA (fever), CHILLS (chills) and NAUSEA (feels nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       .
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Nausea, Pyrexia, Vaccination complication, Vaccination site pain
Clinical narrative: Having reactions to the 2nd shot; Throwing up multiple times; Nauseous; Arm was hurting; Slowly started to have spiking fever,fever of 100.9 degrees Fahrenheit; Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm was sore), VACCINATION COMPLICATION (Having reactions to the 2nd shot), VACCINATION SITE PAIN (Arm was hurting), PYREXIA (Slowly started to have spiking fever,fever of 100.9 degrees Fahrenheit) and NAUSEA (Nauseous) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0022M0A and 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included FAMOTIDINE, PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]), DEXLANSOPRAZOLE (DEXILANT), LORAZEPAM (ATIVAN) and VITAMINS NOS for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE PAIN (Arm was sore). On 26-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Arm was hurting) and PYREXIA (Slowly started to have spiking fever,fever of 100.9 degrees Fahrenheit). On 27-Mar-2021, the patient experienced NAUSEA (Nauseous). On an unknown date, the patient experienced VACCINATION COMPLICATION (Having reactions to the 2nd shot) and VOMITING (Throwing up multiple times). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) on 26-Mar-2021 for Pyrexia, at a dose of 1 dosage form; PARACETAMOL (TYLENOL) on 26-Mar-2021 for Pyrexia, at a dose of 1 dosage form and ONDANSETRON (ZOFRAN [ONDANSETRON]) on 27-Mar-2021 for Nausea, at a dose of 1 dosage form. At the time of the report, VACCINATION SITE PAIN (Arm was sore), VACCINATION COMPLICATION (Having reactions to the 2nd shot), VACCINATION SITE PAIN (Arm was hurting) and VOMITING (Throwing up multiple times) outcome was unknown and PYREXIA (Slowly started to have spiking fever,fever of 100.9 degrees Fahrenheit) and NAUSEA (Nauseous) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Mar-2021, Body temperature: 100.9 (High) High.         Concomitant medications used by the patient includes Birth Control patch (NOS).   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: Added new events.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Having reactions to the 2nd shot; Throwing up multiple times; Nauseous; Arm was hurting; Slowly started to have spiking fever,fever of 100.9 degrees Fahrenheit; Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm was sore), VACCINATION COMPLICATION (Having reactions to the 2nd shot), VACCINATION SITE PAIN (Arm was hurting), PYREXIA (Slowly started to have spiking fever,fever of 100.9 degrees Fahrenheit) and NAUSEA (Nauseous) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0022M0A and 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included FAMOTIDINE, PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]), DEXLANSOPRAZOLE (DEXILANT), LORAZEPAM (ATIVAN) and VITAMINS NOS for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE PAIN (Arm was sore). On 26-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Arm was hurting) and PYREXIA (Slowly started to have spiking fever,fever of 100.9 degrees Fahrenheit). On 27-Mar-2021, the patient experienced NAUSEA (Nauseous). On an unknown date, the patient experienced VACCINATION COMPLICATION (Having reactions to the 2nd shot) and VOMITING (Throwing up multiple times). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) on 26-Mar-2021 for Pyrexia, at a dose of 1 dosage form; PARACETAMOL (TYLENOL) on 26-Mar-2021 for Pyrexia, at a dose of 1 dosage form and ONDANSETRON (ZOFRAN [ONDANSETRON]) on 27-Mar-2021 for Nausea, at a dose of 1 dosage form. At the time of the report, VACCINATION SITE PAIN (Arm was sore), VACCINATION COMPLICATION (Having reactions to the 2nd shot), VACCINATION SITE PAIN (Arm was hurting) and VOMITING (Throwing up multiple times) outcome was unknown and PYREXIA (Slowly started to have spiking fever,fever of 100.9 degrees Fahrenheit) and NAUSEA (Nauseous) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Mar-2021, Body temperature: 100.9 (High) High.         Concomitant medications used by the patient includes Birth Control patch (NOS).   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: Added new events.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Dizziness, Vaccination site pain, Vomiting
Clinical narrative: I felt very weak; had diarrhea; I started to feel dizzy,; and vomiting; my arm was very sore; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (had diarrhea), DIZZINESS (I started to feel dizzy,), ASTHENIA (I felt very weak), VACCINATION SITE PAIN (my arm was very sore) and VOMITING (and vomiting) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included AMLODIPINE for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE PAIN (my arm was very sore). On 23-Feb-2021, the patient experienced DIARRHOEA (had diarrhea), DIZZINESS (I started to feel dizzy,) and VOMITING (and vomiting). On 24-Feb-2021, the patient experienced ASTHENIA (I felt very weak). At the time of the report, DIARRHOEA (had diarrhea), DIZZINESS (I started to feel dizzy,), ASTHENIA (I felt very weak), VACCINATION SITE PAIN (my arm was very sore) and VOMITING (and vomiting) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Pain in extremity, Pyrexia
Clinical narrative: Fever; fatigue; achy joints; headache; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PYREXIA (Fever), FATIGUE (fatigue), ARTHRALGIA (achy joints) and HEADACHE (headache) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 25-Mar-2021, the patient experienced PYREXIA (Fever), FATIGUE (fatigue), ARTHRALGIA (achy joints) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (Sore arm), PYREXIA (Fever), FATIGUE (fatigue), ARTHRALGIA (achy joints) and HEADACHE (headache) had resolved.            Patient has stated that he has seen his HCP for his adverse reactions and he was prescribed Steroids after that his issues has resolved immediately.  Concomitant product information was not provided.  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow up document contains significant information- Updated medically confirmation by HCP , Provided treatment information and Updated Events outcome as Recovered
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Urinary tract infection
Clinical narrative: Skin Blisters; developed a UTI; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Skin Blisters) and URINARY TRACT INFECTION (developed a UTI) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced URINARY TRACT INFECTION (developed a UTI). On 22-Mar-2021, the patient experienced BLISTER (Skin Blisters). The patient was treated with CIPROFLOXACIN HYDROCHLORIDE (CIPROFLACIN) for UTI, at an unspecified dose and frequency. At the time of the report, BLISTER (Skin Blisters) and URINARY TRACT INFECTION (developed a UTI) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No concomitant medications were reported
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pain in extremity, Pre-existing condition improved
Clinical narrative: Upper body aches after 2nd dose; Chills after 2nd dose; Leg aches after 2nd dose; Arm better quicker after 2nd dose; Headache after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Upper body aches after 2nd dose), CHILLS (Chills after 2nd dose), PAIN IN EXTREMITY (Leg aches after 2nd dose), PRE-EXISTING CONDITION IMPROVED (Arm better quicker after 2nd dose) and HEADACHE (Headache after 2nd dose) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022m20a and 046a21a) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced PAIN (Upper body aches after 2nd dose), CHILLS (Chills after 2nd dose), PAIN IN EXTREMITY (Leg aches after 2nd dose), PRE-EXISTING CONDITION IMPROVED (Arm better quicker after 2nd dose) and HEADACHE (Headache after 2nd dose). At the time of the report, PAIN (Upper body aches after 2nd dose), CHILLS (Chills after 2nd dose), PAIN IN EXTREMITY (Leg aches after 2nd dose), PRE-EXISTING CONDITION IMPROVED (Arm better quicker after 2nd dose) and HEADACHE (Headache after 2nd dose) outcome was unknown. Not Provided          No relevant concomitant medication was reported.  Treatment details included, acetaminophen.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: Body ache; Chills; Fever 101.5degree F; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body ache), CHILLS (Chills) and PYREXIA (Fever 101.5degree F) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced MYALGIA (Body ache), CHILLS (Chills) and PYREXIA (Fever 101.5degree F). At the time of the report, MYALGIA (Body ache), CHILLS (Chills) and PYREXIA (Fever 101.5degree F) outcome was unknown.            No concomitants were reported. No treatment was reported. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Pain in extremity, Peripheral swelling
Clinical narrative: her eyes had a hard time focusing and feel fatigue; her eyes had a hard time focusing and feel fatigue; she had a hard time getting her rings off, she has a hard time flossing her teeth; her full arm was swollen, it's still swollen, minor progress; pain on the inside of her arm; chills; a little bit of soreness at the injection site; nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain on the inside of her arm), PERIPHERAL SWELLING (her full arm was swollen, it's still swollen, minor progress), PAIN IN EXTREMITY (she had a hard time getting her rings off, she has a hard time flossing her teeth), VISION BLURRED (her eyes had a hard time focusing and feel fatigue) and CHILLS (chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included PRAVASTATIN SODIUM (PRAVASTINE) and DILTIAZEM for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced CHILLS (chills), VACCINATION SITE PAIN (a little bit of soreness at the injection site) and NAUSEA (nausea). On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain on the inside of her arm). On 20-Mar-2021, the patient experienced PERIPHERAL SWELLING (her full arm was swollen, it's still swollen, minor progress). On 22-Mar-2021, the patient experienced PAIN IN EXTREMITY (she had a hard time getting her rings off, she has a hard time flossing her teeth). On an unknown date, the patient experienced VISION BLURRED (her eyes had a hard time focusing and feel fatigue) and FATIGUE (her eyes had a hard time focusing and feel fatigue). At the time of the report, PAIN IN EXTREMITY (pain on the inside of her arm), PERIPHERAL SWELLING (her full arm was swollen, it's still swollen, minor progress), PAIN IN EXTREMITY (she had a hard time getting her rings off, she has a hard time flossing her teeth), VISION BLURRED (her eyes had a hard time focusing and feel fatigue), CHILLS (chills), FATIGUE (her eyes had a hard time focusing and feel fatigue), VACCINATION SITE PAIN (a little bit of soreness at the injection site) and NAUSEA (nausea) outcome was unknown.            Treatment included Advel, Ice. Eye drops
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vision blurred
Clinical narrative: her eyes had a hard time focusing and feel fatigue; her eyes had a hard time focusing and feel fatigue; she had a hard time getting her rings off, she has a hard time flossing her teeth; her full arm was swollen, it's still swollen, minor progress; pain on the inside of her arm; chills; a little bit of soreness at the injection site; nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain on the inside of her arm), PERIPHERAL SWELLING (her full arm was swollen, it's still swollen, minor progress), PAIN IN EXTREMITY (she had a hard time getting her rings off, she has a hard time flossing her teeth), VISION BLURRED (her eyes had a hard time focusing and feel fatigue) and CHILLS (chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included PRAVASTATIN SODIUM (PRAVASTINE) and DILTIAZEM for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced CHILLS (chills), VACCINATION SITE PAIN (a little bit of soreness at the injection site) and NAUSEA (nausea). On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain on the inside of her arm). On 20-Mar-2021, the patient experienced PERIPHERAL SWELLING (her full arm was swollen, it's still swollen, minor progress). On 22-Mar-2021, the patient experienced PAIN IN EXTREMITY (she had a hard time getting her rings off, she has a hard time flossing her teeth). On an unknown date, the patient experienced VISION BLURRED (her eyes had a hard time focusing and feel fatigue) and FATIGUE (her eyes had a hard time focusing and feel fatigue). At the time of the report, PAIN IN EXTREMITY (pain on the inside of her arm), PERIPHERAL SWELLING (her full arm was swollen, it's still swollen, minor progress), PAIN IN EXTREMITY (she had a hard time getting her rings off, she has a hard time flossing her teeth), VISION BLURRED (her eyes had a hard time focusing and feel fatigue), CHILLS (chills), FATIGUE (her eyes had a hard time focusing and feel fatigue), VACCINATION SITE PAIN (a little bit of soreness at the injection site) and NAUSEA (nausea) outcome was unknown.            Treatment included Advel, Ice. Eye drops
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient received 0.25ml dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INCORRECT DOSE ADMINISTERED (Patient received 0.25ml dose) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 25-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (Patient received 0.25ml dose). At the time of the report, INCORRECT DOSE ADMINISTERED (Patient received 0.25ml dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details for events was not provided.   This report refers to a case of incorrect dose administered for mRNA-1273, lot # 017B21A with no associated AEs.   Reporter did not allow further contact
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Bee-Sting like big spot on the Injection Site ( > 3") /Red (more than 3 inches oval shape); Swollen Injection Site; Warm to the touch Injection Site; Itching Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Bee-Sting like big spot on the Injection Site ( > 3") /Red (more than 3 inches oval shape)), VACCINATION SITE SWELLING (Swollen Injection Site), VACCINATION SITE WARMTH (Warm to the touch Injection Site) and INJECTION SITE PRURITUS (Itching Injection Site) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was provided.).    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Bee-Sting like big spot on the Injection Site ( > 3") /Red (more than 3 inches oval shape)), VACCINATION SITE SWELLING (Swollen Injection Site), VACCINATION SITE WARMTH (Warm to the touch Injection Site) and INJECTION SITE PRURITUS (Itching Injection Site). At the time of the report, VACCINATION SITE ERYTHEMA (Bee-Sting like big spot on the Injection Site ( > 3") /Red (more than 3 inches oval shape)), VACCINATION SITE SWELLING (Swollen Injection Site), VACCINATION SITE WARMTH (Warm to the touch Injection Site) and INJECTION SITE PRURITUS (Itching Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Discomfort, Fatigue, Headache, Hyperhidrosis
Clinical narrative: sweaty; nausea; When she has her arm down and tries to lift it up, it hurts; Joint in the right arm was hurting; it becomes a little bit more uncomfortable at nigh; headache; feeling tired; pain in her arm; vomited; motions; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (vomited), MOTION SICKNESS (motions), HEADACHE (headache), FATIGUE (feeling tired) and PAIN IN EXTREMITY (pain in her arm) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced VOMITING (vomited) and MOTION SICKNESS (motions). On 26-Mar-2021, the patient experienced HEADACHE (headache), FATIGUE (feeling tired) and PAIN IN EXTREMITY (pain in her arm). On an unknown date, the patient experienced HYPERHIDROSIS (sweaty), NAUSEA (nausea), PAIN (When she has her arm down and tries to lift it up, it hurts), ARTHRALGIA (Joint in the right arm was hurting) and DISCOMFORT (it becomes a little bit more uncomfortable at nigh). On 25-Mar-2021, VOMITING (vomited) and MOTION SICKNESS (motions) had resolved. At the time of the report, HEADACHE (headache), FATIGUE (feeling tired) and PAIN IN EXTREMITY (pain in her arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medication was reported.  Treatment details included. acetaminophen.